Court Makes Preliminary Finding That Oasis Medical, Inc. has Infringed Bausch & Lomb's ACCUGLIDE Blade Patent.Business/Legal Editors ROCHESTER, N.Y.--(BUSINESS WIRE)--July 24, 2001 In a lawsuit filed by Bausch & Lomb (NYSE NYSE See: New York Stock Exchange :BOL BOL Bolivia (ISO Country code) BOL Books Online BOL Bole (SIL code, Nigeria) BOL Bill Of Lading BOL Beginning Of Line BOL Best Of Luck BOL Buzz Out Loud BOL Bruin Online BOL Beginning Of Life ) charging that Oasis Medical Inc. has infringed Bausch & Lomb's ACCUGLIDE(R) blade patent, the United States District Court United States District Court In the U.S., any of the 94 trial courts of general jurisdiction in the federal judicial system. Each state, as well as the District of Columbia and the Commonwealth of Puerto Rico, has at least one federal district court. for the Central District of California has denied motions by Oasis for summary judgment. The Accuglide blade is a key component of Bausch & Lomb's market-leading Hansatome(R) microkeratome, an instrument used in refractive surgery Refractive surgery A surgical procedure that corrects visual defects. Mentioned in: Photorefractive Keratectomy and Laser-Assisted In-Situ Keratomileusis refractive surgery . In its ruling on July 18, the Court found that Bausch & Lomb has made a prima facie case prima facie case n. a plaintiff's lawsuit or a criminal charge which appears at first blush to be "open and shut." (See: prima facie) for infringement of the patent and has ordered that the case proceed. Bausch & Lomb remains confident that it will prevail and looks forward to an early resolution of the lawsuit. Bausch & Lomb Incorporated is the preeminent global technology-based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology and design. Its core businesses include soft and rigid gas permeable gas permeable gas adj (lenses) → luftdurchlässig contact lenses, lens care products, ophthalmic surgical and pharmaceutical products. The company is advantaged with some of the most respected brands in the world starting with its name, Bausch & Lomb(R), and including SofLens(R), PureVision(TM), Boston(R), ReNu(R), Storz(R) and Technolas(TM). Founded in 1853 in Rochester, N.Y., where it continues to have its headquarters, the company has annual revenues of approximately $1.8 billion and employs approximately 12,000 people in more than 50 countries. Bausch & Lomb products are available in more than 100 countries around the world. Additional information about the company can be found on Bausch & Lomb's Worldwide Web site at http://www.bausch.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion